By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
GMJ NewsGMJ NewsGMJ News
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Notification Show More
Font ResizerAa
GMJ NewsGMJ News
Font ResizerAa
  • Latest News
    • GMJ Briefs
  • Podcast & Media
    • Podcast Episodes
    • GMJ Audio
    • GMJ Videos
  • Research Digest
    • New Studies
    • Georgian Research
    • Data & Numbers
  • Policy & Systems
    • Health Policy
    • Quality & Safety
    • Migration & Health
    • Global Health
  • Practice
    • Clinical Updates
    • Case Discussions
    • Pharmacy & Prescribing
    • Ingredients A-Z
  • Perspectives
    • Editorial
    • Explainers
    • Voices
    • Letters
  • GMJ Articles
    • Vol. 1 Issue 2 (2026)
    • Vol. 1 Issue 1 (2026)
    • Pre-Launch Articles (2025)
  • Read the Journal →
  • About GMJ News
Follow US
GMJ News > Drugs A-Z > Beta-blocker > Labetalol

Labetalol

GMJ
Last updated: 02/06/2026 14:31
By
Prof. Giorgi Pkhakadze
Share
5 Min Read
SHARE
3 min read|657 words

Labetalol: A Dual-Action Blood Pressure Medication

What is Labetalol?

Labetalol is a prescription medication that belongs to a unique class of beta-blockers with additional alpha-blocking properties. It is primarily used to treat high blood pressure (hypertension) and is particularly valuable in emergency situations where rapid blood pressure reduction is needed. Unlike traditional beta-blockers, labetalol blocks both alpha and beta receptors in the cardiovascular system, making it especially effective for certain patients.

Uses

Labetalol is approved and commonly used for several cardiovascular conditions:

  • Hypertension: The primary use is treating chronic high blood pressure, both as a first-line treatment and in combination with other medications
  • Hypertensive emergencies: Administered intravenously in hospitals to rapidly lower dangerously high blood pressure
  • Pregnancy-related hypertension: Considered one of the safer options for treating high blood pressure during pregnancy, including preeclampsia
  • Post-surgical blood pressure control: Used to manage blood pressure spikes that can occur after certain surgical procedures
  • Heart rate control: Helps reduce elevated heart rate in patients with certain cardiovascular conditions

How it works

Labetalol works by blocking both alpha-1 and beta receptors in the cardiovascular system. The beta-blocking action reduces heart rate and the force of heart contractions, while the alpha-blocking effect causes blood vessels to relax and widen. This dual mechanism results in reduced blood pressure through multiple pathways, making it particularly effective compared to medications that target only one type of receptor.

Side effects

Common side effects include:

Submit Your Paper
GMJ_Submit_Banner
  • Dizziness or lightheadedness
  • Fatigue or weakness
  • Nausea
  • Headache
  • Cold hands and feet
  • Difficulty sleeping
  • Decreased exercise tolerance
  • Scalp tingling (unique to labetalol)

Serious side effects requiring immediate medical attention:

  • Severe difficulty breathing or wheezing
  • Chest pain or irregular heartbeat
  • Severe dizziness or fainting
  • Signs of liver problems (yellowing of skin or eyes, dark urine)
  • Severe allergic reactions (rash, swelling, difficulty breathing)

Warnings and precautions

Several important safety considerations apply to labetalol use:

  • Asthma and COPD: Should be avoided in patients with severe asthma or chronic obstructive pulmonary disease, as it can worsen breathing difficulties
  • Heart conditions: Use with caution in patients with heart failure, certain heart rhythm disorders, or very slow heart rate
  • Diabetes: May mask symptoms of low blood sugar and can affect blood glucose levels
  • Liver function: Requires monitoring in patients with liver disease, as rare cases of liver injury have been reported
  • Pregnancy category C: Generally considered safer than many other blood pressure medications during pregnancy, but should only be used when benefits outweigh risks
  • Sudden discontinuation: Should not be stopped abruptly, as this can cause dangerous rebound high blood pressure

Interactions

Labetalol can interact with numerous medications and substances:

  • Calcium channel blockers: Can cause excessive lowering of blood pressure and heart rate when combined
  • Insulin and diabetes medications: May enhance blood sugar-lowering effects and mask hypoglycemia symptoms
  • NSAIDs (ibuprofen, naproxen): Can reduce the blood pressure-lowering effectiveness of labetalol
  • Digoxin: Labetalol may increase digoxin levels, requiring dose adjustments
  • Anesthetics: Can cause excessive blood pressure reduction during surgery
  • Tricyclic antidepressants: May interfere with labetalol’s blood pressure-lowering effects
  • Alcohol: Can enhance the blood pressure-lowering effect and increase dizziness risk
  • Epinephrine: Beta-blockers can interfere with epinephrine’s effectiveness in treating severe allergic reactions

Check interactions with the GMJ Interaction Checker

Dosage

Typical adult dosage ranges vary based on the condition being treated and individual patient response. For oral treatment of hypertension, the usual starting dose is 100 mg twice daily, which may be gradually increased to 200-400 mg twice daily as needed. Maximum daily doses typically do not exceed 800-1200 mg. For intravenous use in emergency situations, doses are carefully calculated based on patient weight and blood pressure response. Dosage adjustments may be necessary for patients with liver impairment. All dosing decisions should be made by a qualified healthcare provider based on individual patient factors and response to treatment.

Sources: FDA DailyMed drug labels (public domain), BNF, WHO Essential Medicines List. This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting or stopping any medication.

Cite this page

GMJ News Desk. "Labetalol." GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/drug/labetalol/

CC BY 4.0This work is licensed under Creative Commons Attribution 4.0 International (CC BY 4.0). You are free to share and adapt this content with attribution to GMJ News (news.gmj.ge).

Was this article helpful?

Share This Article
Facebook LinkedIn Bluesky Copy Link Print
GMJ
ByProf. Giorgi Pkhakadze
Follow:
Prof. Giorgi Pkhakadze, MD, MPH, PhD, is Editor-in-Chief of the Georgian Medical Journal and Chair of the Public Health Institute of Georgia (PHIG). He is Professor and Head of the Department of Social and Behavioural Sciences at David Tvildiani Medical University, and Secretary/Treasurer of the UEMS Section of Public Health. ORCID: 0000-0001-7609-4515.

Submit Your Paper →

Georgia's peer-reviewed open-access medical journal. No APC until January 2027.
Submit Manuscript →
How amino acids shape brain function: neurotransmitters, energy, and cognitive resilience

Amino acids are the precursors to neurotransmitters and metabolic substrates for brain…

How Coffee and Tea Reduce Iron Absorption: A Mechanism Explained

Polyphenols in coffee and tea bind non-heme iron in the gut, reducing…

Eggs and Alzheimer’s risk: New evidence from a 15-year study challenges decades of dietary caution

A 15-year study of 39,498 older adults found that eating eggs five…

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →

You Might Also Like

Propranolol

By
Prof. Giorgi Pkhakadze
02/06/2026

Metoprolol

By
Prof. Giorgi Pkhakadze
02/06/2026

Sotalol

By
Prof. Giorgi Pkhakadze
02/06/2026

Atenolol

By
Prof. Giorgi Pkhakadze
02/06/2026
Facebook Twitter Youtube Instagram
Company
  • Privacy Policy
  • Contact US
  • GMJ Journal
  • Submit Manuscript
  • Editorial Team
  • Register at GMJ
  • Terms of Use

Subscribe to GMJ News — Click here

Join Community
© 2026 Georgian Medical Journal (GMJ). Published by the Public Health Institute of Georgia (PHIG). All rights reserved.
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?

Not a member? Sign Up